https://www.youtube.com/watch?v=Jg1kT10sho4&ab_channel=WomeninHealthcare-Japan Yuuri Ueda- After acquiring BA in law at Waseda university, Yuuri became MD at Okayama university. Her sub-specialities are plastic surgery and home care medicine, mainly takes care of decubitus in elders at home.  As well as continuing her clinical practice, she started her career as a director for MedPeer–Japan from April, 2017. she takes a part in organizing  SUM Healthtech  conferences in Japan, one of the biggest and the most active conference in Health IT and technology industry She is heavily motivated in integrating medical practice and technologies, as she sees real needs for technologies in clinical situation.

https://www.youtube.com/watch?v=vUm5NX5mVWc&ab_channel=WomeninHealthcare-Japan Welcome back to Women in Healthcare Japan! Today we are honored with a very special guest, Susie Barnes. She is a British Physician who trained at Imperial College of London and is also a member of Royal College of General Practitioners and Fellow of the Faculty of Pharmaceutical Medicine, a Faculty of the Royal College of Physicians, in the UK She worked for the UK’s National Health Service for 10 years in Anesthesiology and general practice. She then transitioned into the industry as a Medical Advisor at Servier Laboratories there she worked into multiple roles of increasing responsibility across Medical,Regulatory and Health Economics In 2014, She joined GSK UK as Associate Medical Director. She then transferred to GSK Canada as Respiratory Medical Director to then become the VP and Country Medical Director of GSK Canada. In 2018, She transferred here, where she became VP and Head of Medical GSK Japan. Just recently in 2021, she took on the role of VP, Country Medical Director and Head of R&D for GSK Japan. She is also a member of WLI here in Japan!

Rami Suzuki joined us on our very first “Women in Healthcare Podcast-Japan”. We discussed how she became the leader that she is today as well as some of the gender gap issues we see here in Japan. Rami Suzuki joined Ferring as Chief Executive Officer in November 2020. Prior to joining Ferring, she was at Janssen Japan as the head of Medical Affairs Function and at Eisai Co., Ltd. as corporate officer in charge of corporate business development. Today she serves the Ministry of Education, Culture, Sports, Science and Technology (MEXT) as Life Science Committee member as well as Japan Agency for Medical Research and Development (AMED) and Japan Science and Technology Agency (JST) as an advisor to several projects. She was a selection committee member of Medical Science and Medicinal Science for Japan Prize 2018. She obtained her Ph.D. in Medicine at University College London with a scholarship from Ludwig Institute for Cancer Research. Her postdoctoral research was on breast cancer at Imperial College, London.